ArticleFuture oncology (London, England)2025
Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma.
Lucio N Gordan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it